Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Appeal a Denial: If your initial request is denied, dont lose hope
The Legal Arguments Plaintiffs Claim: Manufacturers (Novo Nordisk, Eli Lilly) knew or should have known about risks of gastroparesis and NAION Warning labels failed to adequately disclose these serious side effects Drugs were aggressively marketed as safe and effective weight loss solutions without proper risk disclosure Patients would not have taken the medications had they known the true risks Defendants Respond: Claims are unfounded (Novo Nordisk statement) Will defend vigorously against lawsuits Motion to dismiss expected January 24, 2025 Argue that labels were adequate and that many conditions may be pre-existing or related to diabetes itself Whos Most at Risk
The protocol is complete at 4, and the 4-month rest that follows is as important as the active cycle itself
Patients who engage fully with their medical team, attend follow-up appointments consistently, and make supportive lifestyle adjustments tend to achieve the most impressive and sustainable outcomes
GPhC chief executive Duncan Rudkin said: "We know online pharmacy services can provide a very valuable service - but through our inspections and investigations, we've seen too many cases of medicines being supplied inappropriately online and putting people at risk." Weight-loss drugs are now classed as "high risk" medicines, requiring extra safeguards, and are offered on the NHS with very strict criteria
A high-fat meal will sit in your stomach for hours, increasing fermentation and acid reflux
